| 9/9/26 |
Tyra Biosciences (TYRA) |
TYRA-300 for Bladder Cancer |
Subscribers Only |
Subscribers Only |
Subscribers Only |
| 9/8/26 |
Structure (GPCR) |
aleniglipron for Obesity |
Subscribers Only |
Subscribers Only |
Subscribers Only |
| 9/8/26 |
Bristol Myers Squibb (BMY) |
Arlo-cel for Multiple Myeloma (MM) |
Subscribers Only |
Subscribers Only |
Subscribers Only |
| 9/2/26 |
Teva Pharmaceutical Industries (TEVA) |
TEV-53408 for Celiac Disease |
Subscribers Only |
Subscribers Only |
Subscribers Only |
| 9/2/26 |
Jiangsu Hengrui Pharmaceuticals (600276:SS) |
SHR-1918 for Dyslipidemia / Hypercholesterolemia |
Subscribers Only |
Subscribers Only |
Subscribers Only |